| Bilgi: |
Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
This report describes vaccine effectiveness of COVID-19 booster doses after one dose of the Johnson & Johnson COVID-19 vaccine against emergency department, urgent care visits, and hospitalizations.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=663826
|
